At close: 5:24:06 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-8,440.0000
-8,440.0000
-10,801.0000
-9,858.0000
-12,063.0000
Investing Cash Flow
498.0000
498.0000
9,502.0000
-14,511.0000
-26.0000
Financing Cash Flow
9,144.0000
9,144.0000
--
20,457.0000
17,683.0000
End Cash Position
4,278.0000
4,278.0000
2,978.0000
4,390.0000
8,268.0000
Interest Paid Supplemental Data
--
--
--
18.0000
23.0000
Capital Expenditure
-2.0000
-2.0000
-9.0000
-11.0000
-26.0000
Issuance of Capital Stock
9,144.0000
9,144.0000
--
20,457.0000
17,683.0000
Free Cash Flow
-8,442.0000
-8,442.0000
-10,810.0000
-9,869.0000
-12,089.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PLUR.TA Pluri Inc.
1,667.00
+1.46%
BBIXF Bonus BioGroup Ltd.
0.0200
-60.78%
ALZ.ST Alzinova AB (publ)
3.3000
-3.51%
CGEN.TA Compugen Ltd.
596.60
+2.09%
BONS.TA Bonus BioGroup Ltd.
18.60
+17.72%
ENLV.TA Enlivex Therapeutics Ltd.
438.30
-4.13%
CLGN CollPlant Biotechnologies Ltd.
4.4126
+4.32%
KRRO Korro Bio, Inc.
41.31
-3.57%
EVGN Evogene Ltd.
1.8500
-2.63%
ENLV Enlivex Therapeutics Ltd.
1.2250
-2.01%